🇺🇸 FDA
Patent

US 10051880

Hydroxybutyrate ester and medical use thereof

granted A61KA61K31/22A61P

Quick answer

US patent 10051880 (Hydroxybutyrate ester and medical use thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Aug 21 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/22, A61P, A61P21/00, A61P25/16